Fluphenazine/olanzapine/ziprasidone: Movement disorders and sedation: case report

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1292, 2010-01, pp. : 17-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antipsychotics: NMS (fluphenazine) and elevated serum CK levels (risperidone, olanzapine, quetiapine and ziprasidone): case report

Reactions Weekly, Vol. 1, Iss. 1266, 2009-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Olanzapine/ziprasidone: Weight gain and pruritus: case report

Reactions Weekly, Vol. 1, Iss. 1356, 2011-01 ,pp. : 27-28

Adis International

Access to resources Recommend Favorite

Ziprasidone: Sedation, increased motor drive and first report of sialorrhoea: case report

Reactions Weekly, Vol. 1, Iss. 1071, 2005-01 ,pp. : 14-15

Adis International

Access to resources Recommend Favorite

Amisulpride/quetiapine/ziprasidone: Movement disorders in a patient with a heterozygous dopamine receptor D3 gene mutation: case report

Reactions Weekly, Vol. 1, Iss. 1181, 2007-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Olanzapine/risperidone/ziprasidone: First report of seborrhoeic dermatitis: 3 case reports

Reactions Weekly, Vol. 1, Iss. 1158, 2007-01 ,pp. : 21-22

Adis International

Access to resources Recommend Favorite